Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7Q9P | P0DTC2 | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9P | 7Q9P | Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9M | P0DTC2 | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9M | 7Q9M | Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9K | P0DTC2 | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9K | 7Q9K | Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9J | P0DTC2 | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9J | 7Q9J | Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9I | P0DTC2 | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9I | 7Q9I | Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9G | P0DTC2 | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9G | 7Q9G | COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9F | P0DTC2 | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q9F | 7Q9F | Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein | |
| 7Q6E | P0DTC2 | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
| 7Q6E | 7Q6E | Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores the antigenic distance to other SARS-CoV-2 variants | |
| 7Q62 | A8K2U0 | Structure of TEV cleaved A2ML1 dimer (A2ML1-TT dimer) | |
| 7Q61 | A8K2U0 | Structure of TEV conjugated A2ML1 (A2ML1-TC) | |
| 7Q5D | Q9UNN8 | Structure of EPCR in a non-canonical conformation | |
| 7Q5C | P76045 | Crystal structure of OmpG in space group 96 | |
| 7Q4T | F4YDQ3 | Structure of the Pseudomonas aeruginosa bacteriophage JG004 endolysin Pae87 bound to a peptidoglycan fragment. | |
| 7Q4T | 7Q4T | Structure of the Pseudomonas aeruginosa bacteriophage JG004 endolysin Pae87 bound to a peptidoglycan fragment. | |
| 7Q4I | Q7K237 | Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP | |
| 7Q4I | P15941 | Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP | |
| 7Q4E | P12821 | Local refinement structure of a single N-domain of full-length, dimeric, soluble somatic angiotensin I-converting enzyme | |
| 7Q4D | P12821 | Local refinement structure of the two interacting N-domains of full-length, dimeric, soluble somatic angiotensin I-converting enzyme | |
| 7Q4C | P12821 | Local refinement structure of the C-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme | |
| 7Q49 | P12821 | Local refinement structure of the N-domain of full-length, monomeric, soluble somatic angiotensin I-converting enzyme | |
| 7Q3Y | P12821 | Structure of full-length, monomeric, soluble somatic angiotensin I-converting enzyme showing the N- and C-terminal ellipsoid domains | |
| 7Q3R | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
| 7Q3R | 7Q3R | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 | |
| 7Q3Q | A0A6H2EIN2 | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 | |
| 7Q3Q | 7Q3Q | Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 | |
| 7Q3P | 7Q3P | Crystal structure of IgG1-Fc-MST-HN (efgartigimod) | |
| 7Q3N | Q1R2J4 | Cryo-EM of the complex between human uromodulin (UMOD)/Tamm-Horsfall protein (THP) and the FimH lectin domain from uropathogenic E. coli | |
| 7Q3N | P07911 | Cryo-EM of the complex between human uromodulin (UMOD)/Tamm-Horsfall protein (THP) and the FimH lectin domain from uropathogenic E. coli | |
| 7Q29 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD013 | |
| 7Q28 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD012 | |
| 7Q27 | P12821 | Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD011 | |
| 7Q26 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD013 | |
| 7Q25 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD012 | |
| 7Q24 | P12821 | Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD011 | |
| 7Q20 | A7B6A6 | Ruminococcus gnavus ATC29149 endo-beta-1,4-galactosidase (RgGH98) in complex with blood group A trisaccharide | |
| 7Q1Z | P0DTC2 | Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein | |
| 7Q1Y | A8K2U0 | X-ray structure of human A2ML1 | |
| 7Q1W | A7B6A6 | Ruminococcus gnavus ATC29149 endo-beta-1,4-galactosidase (RgGH98) E411A in complex with blood group A (BgA II) tetrasaccharide | |
| 7Q1P | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1O | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-3,3-diphenylpropanamide | |
| 7Q1N | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2R)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide | |
| 7Q1M | P06276 | Crystal structure of human butyrylcholinesterase in complex with N-[(2S)-3-[(cyclohexylmethyl)amino]-2-hydroxypropyl]-2,2-diphenylacetamide |
